AU2003219955A1 - Isoquinoline-3-carboxylic acid derivatives as excitatory amino acid receptor antagonists - Google Patents
Isoquinoline-3-carboxylic acid derivatives as excitatory amino acid receptor antagonistsInfo
- Publication number
- AU2003219955A1 AU2003219955A1 AU2003219955A AU2003219955A AU2003219955A1 AU 2003219955 A1 AU2003219955 A1 AU 2003219955A1 AU 2003219955 A AU2003219955 A AU 2003219955A AU 2003219955 A AU2003219955 A AU 2003219955A AU 2003219955 A1 AU2003219955 A1 AU 2003219955A1
- Authority
- AU
- Australia
- Prior art keywords
- isoquinoline
- receptor antagonists
- amino acid
- excitatory amino
- carboxylic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES02380067.5 | 2002-03-22 | ||
ES200203867 | 2002-03-22 | ||
US44134503P | 2003-01-17 | 2003-01-17 | |
US60/441,345 | 2003-01-17 | ||
PCT/US2003/006156 WO2003082856A1 (en) | 2002-03-22 | 2003-03-12 | Isoquinoline-3-carboxylic acid derivatives as excitatory amino acid receptor antagonists |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2003219955A1 true AU2003219955A1 (en) | 2003-10-13 |
Family
ID=28676454
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2003219955A Abandoned AU2003219955A1 (en) | 2002-03-22 | 2003-03-12 | Isoquinoline-3-carboxylic acid derivatives as excitatory amino acid receptor antagonists |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2003219955A1 (en) |
WO (1) | WO2003082856A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100436446C (en) | 2002-04-26 | 2008-11-26 | 伊莱利利公司 | Ester derivatives of a decahydroisoquinoline-3-carboxylic acid as analgestics |
TWI593692B (en) * | 2013-03-12 | 2017-08-01 | 美國禮來大藥廠 | Tetrahydropyrrolothiazine compounds |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5284957A (en) * | 1992-09-03 | 1994-02-08 | Eli Lilly And Company | Excitatory amino acid receptor antagonists |
-
2003
- 2003-03-12 AU AU2003219955A patent/AU2003219955A1/en not_active Abandoned
- 2003-03-12 WO PCT/US2003/006156 patent/WO2003082856A1/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2003082856A1 (en) | 2003-10-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL174299A0 (en) | Bicyclic [3.1.0] derivatives as glycine transporter inhibitors | |
AU2003299807A1 (en) | Heteroarylalkanoic acids as integrin receptor antagonists | |
AU2003245700A1 (en) | Pyrazolopyridine derivatives | |
AU2003261392A1 (en) | M3muscarinic acetylcholine receptor antagonists | |
AU2003231513A1 (en) | Pgd2 receptor antagonist | |
AU2003260345A1 (en) | 2-phenylpyridin-4-yl derivatives as alk5 inhibitors | |
AU2005234596A8 (en) | Piperazinylpiperidine derivatives as chemokine receptor antagonists | |
AU2003273989A1 (en) | Quinazolinone derivatives useful as anti-hyperalgesic agents | |
AU2002953255A0 (en) | Protein kinase inhibitors | |
AU1433901A (en) | Excitatory amino acid derivatives | |
AU2003299600A1 (en) | The r-isomer of beta amino acid compounds as integrin receptor antagonists derivatives | |
AU2003255501A1 (en) | Cxcr4 receptor antagonists | |
AU2003269421A1 (en) | Hiv-integrase inhibitors, pharmaceutical compositions, and methods for their use | |
AU2003280838A1 (en) | Indole derivatives as somatostatin agonists or antagonists | |
AU2003267088A1 (en) | Chemokine receptor antagonists as therapeutic agents | |
EP1552826A4 (en) | Amino acid compositions for improving central functions | |
AU2002356369A1 (en) | Xanthine derivatives as muscarinic receptor antagonists | |
AU2003300904A1 (en) | Antagonists for human prolactin | |
AU2002347552A1 (en) | 1-substituted-3-pyrrolidine derivatives as muscarinic receptor antagonists | |
AU2003240705A1 (en) | Morpholinylmethylureas ccr-3 receptor antagonists | |
AUPS251502A0 (en) | Protein kinase inhibitors | |
AU2003219955A1 (en) | Isoquinoline-3-carboxylic acid derivatives as excitatory amino acid receptor antagonists | |
AU2003210778A1 (en) | Amino acid transporters | |
AU2002227020A1 (en) | Pyrrolidinylmethyl- and piperidinyl substituted decahydroisoquinolines as excitatory amino acid receptor antagonists | |
AU2003255954A1 (en) | Substituted glycine derivatives for use as medicaments |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |